Polianta Ltd Has $1.79 Million Position in Centene Corporation $CNC

Polianta Ltd trimmed its position in shares of Centene Corporation (NYSE:CNC) by 38.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 27,900 shares of the company’s stock after selling 17,100 shares during the quarter. Polianta Ltd’s holdings in Centene were worth $1,790,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CNC. Vanguard Group Inc. increased its position in Centene by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 56,978,753 shares of the company’s stock valued at $2,344,676,000 after acquiring an additional 190,334 shares during the period. AQR Capital Management LLC grew its stake in shares of Centene by 117.0% in the fourth quarter. AQR Capital Management LLC now owns 31,798,738 shares of the company’s stock worth $1,308,518,000 after purchasing an additional 17,143,904 shares during the last quarter. Geode Capital Management LLC increased its holdings in Centene by 5.5% in the fourth quarter. Geode Capital Management LLC now owns 13,271,492 shares of the company’s stock valued at $554,338,000 after purchasing an additional 697,277 shares during the period. Deerfield Management Company L.P. increased its holdings in Centene by 184.0% in the third quarter. Deerfield Management Company L.P. now owns 9,046,000 shares of the company’s stock valued at $322,761,000 after purchasing an additional 5,860,630 shares during the period. Finally, Morgan Stanley raised its position in Centene by 7.2% during the 4th quarter. Morgan Stanley now owns 9,002,570 shares of the company’s stock worth $370,456,000 after purchasing an additional 603,585 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Analysts Set New Price Targets

CNC has been the topic of a number of analyst reports. Bank of America upped their price target on Centene from $72.00 to $74.00 and gave the company a “buy” rating in a research report on Thursday, June 4th. Royal Bank Of Canada upped their target price on Centene from $70.00 to $71.00 and gave the company a “sector perform” rating in a report on Thursday, July 9th. Sanford C. Bernstein reissued an “outperform” rating and set a $79.00 target price (up from $68.00) on shares of Centene in a research report on Monday, August 3rd. Wells Fargo & Company set a $69.00 price target on shares of Centene and gave the stock an “equal weight” rating in a report on Monday, July 13th. Finally, Zacks Research raised shares of Centene from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, July 29th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, Centene currently has a consensus rating of “Hold” and a consensus price target of $68.58.

Centene Price Performance

Centene stock opened at $65.69 on Friday. The stock has a market capitalization of $32.45 billion, a price-to-earnings ratio of -6.29, a PEG ratio of 0.35 and a beta of 1.08. Centene Corporation has a 52-week low of $25.18 and a 52-week high of $69.36. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.15 and a current ratio of 1.15. The stock’s 50 day moving average price is $64.48 and its two-hundred day moving average price is $50.92.

Centene (NYSE:CNC) last released its quarterly earnings data on Tuesday, July 28th. The company reported $2.51 earnings per share for the quarter, beating the consensus estimate of $1.09 by $1.42. The company had revenue of $53.58 billion during the quarter, compared to analyst estimates of $47.64 billion. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. Centene’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.16) EPS. Centene has set its FY 2026 guidance at 4.800- EPS. On average, equities analysts predict that Centene Corporation will post 4.89 earnings per share for the current year.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.